)
Joe Balleydier, M.A.,
Senior Consultant,
Dark Horse Consulting Group
Joe comes to Dark Horse after 30 years in the biopharmaceutical industry with both large pharma and startup biotech companies. He has broad expertise across multiple biologic modalities including AAVs, recombinant proteins, vaccines, plasmid DNA, and antibodies.
For the past several years, Joe’s primary focus has been with process development and manufacturing of AAV derived gene therapy products. He has held multiple roles across process development, MSAT, and manufacturing at startup gene therapy companies at stages from pre-clinical through commercial operations. Joe’s main contribution to these organizations has been the establishment of robust, scalable, and well-controlled manufacturing processes.